Anlon Healthcare Limited (AHCL) Share Price Today — ₹19.52

Anlon Healthcare Limited (AHCL) live stock price is ₹19.52. Listed on BSE. Sector: Healthcare. Industry: Pharmaceuticals & Biotechnology.

View Anlon Healthcare Limited stock charts, financial results, quarterly earnings, shareholding pattern, corporate actions, peer comparison and more on Black Bear Labs.

Compare with other stocks in the Healthcare sector.

Use our Stock CAGR Calculator to calculate returns for Anlon Healthcare Limited. Screen stocks with our Stock Screener.

Learn about key metrics: P/E Ratio, Market Cap, ROE, EPS.

AHCL

BSE

Anlon Healthcare Limited

Healthcare· Pharmaceuticals & Biotechnology· INE0Y8W01025· Scrip: 544497

EN हिन्दी ગુજરાતી मराठी

₹19.52

▲ 1.96 (+0.00%)

2026-09-11

BSE

₹19.52

▲ 1.96

+0.00%

190 trading days · 1Y period

TODAY (BSE)

Open17.64

High20.00

Low17.52

Prev Close17.56

Volume68.81L

Value₹13.0Cr

L: 17.52H: 20.00

Info

Face Value₹10

Listed2025-09-03

ISININE0Y8W01025

SeriesB

BSE Scrip544497

Key Metrics

1D

—

1W

—

1M

—

3M

—

6M

—

Valuation

P/E (TTM)—

P/E (Qtr Ann.)—

P/Sales—

Mkt Cap—

Growth (QoQ)

Revenue-31.84%

PAT-44.71%

EPS-49.10%

Profitability

EBITDA Margin30.8%

Net Margin14.5%

TTM EBITDA M.—

TTM Net M.—

Dividend

Yield—

Latest DPS—

Payout Ratio—

Growth—

TTM Revenue

—

TTM EBITDA

—

TTM PAT

—

TTM EPS

—

Rev/Share

—

Quarterly Financials

Revenue

EBITDA

PAT

EPS

Quarter	Revenue	Expenses	EBITDA	PBT	PAT	EPS
2025-12-31	36 Cr	25 Cr	11 Cr	11 Cr	5 Cr	₹1.13
2025-09-30	52 Cr	40 Cr	13 Cr	12 Cr	9 Cr	₹2.22
2025-06-30	33 Cr	28 Cr	5 Cr	5 Cr	4 Cr	₹2.22

Shareholding Pattern

CURRENT — 2026-03-31

Promoter52.7%

FII0.3%

DII4.6%

Public47.3%

PROMOTER HOLDING TREND

Corporate Actions

Ex-Date	Type	Purpose
2026-04-24	Bonus	Bonus 1:1
2026-04-24	Split	Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share

Earnings Transcripts

Anlon Healthcare Limited has informed the Exchange about Investor Presentation

5 Aug 2026NSE28K chars

Read →

Anlon Healthcare Limited has informed the Exchange about Investor Presentation

3 Jun 2026NSE27K chars

Read →

Anlon Healthcare Limited has informed the Exchange about Investor Presentation

19 Nov 2025NSE25K chars

Read →

Price History

Date	Open	High	Low	Close	Volume
2026-09-11	17.73	20.00	17.54	19.57	15.07Cr
2026-09-01	15.93	15.97	15.37	15.49	18.80L
2026-08-27	15.10	15.80	15.10	15.60	44.31L
2026-08-11	14.59	14.59	14.36	14.41	13.36L
2026-08-10	14.90	14.92	14.20	14.45	37.48L
2026-07-22	15.37	15.50	14.83	14.87	21.74L
2026-07-17	15.15	15.18	14.70	14.73	29.92L
2026-07-16	15.09	15.36	14.95	15.18	30.89L
2026-07-15	15.12	15.29	15.11	15.16	25.84L
2026-07-14	15.29	15.47	14.99	15.05	32.78L
2026-07-10	15.64	15.72	15.50	15.59	19.52L
2026-07-09	15.15	15.64	15.10	15.47	28.18L
2026-07-08	15.53	15.57	15.00	15.19	38.71L
2026-07-07	15.40	16.07	15.40	15.62	56.43L
2026-07-03	16.12	16.24	15.25	15.87	1.31Cr
2026-07-02	15.96	16.14	15.85	15.90	34.51L
2026-07-01	16.00	16.45	15.87	15.90	59.20L
2026-06-30	16.37	16.50	15.89	15.99	34.89L
2026-06-24	16.19	16.78	16.02	16.13	94.75L
2026-06-10	15.33	15.99	14.30	14.42	1.51Cr
2026-06-03	13.48	13.83	13.48	13.72	9.67L
2026-05-27	14.18	14.35	14.00	14.25	15.42L
2026-05-26	13.77	14.52	13.73	14.05	31.43L
2026-05-25	13.99	14.19	13.70	13.78	8.69L
2026-05-22	14.05	14.24	13.68	13.91	9.51L
2026-05-21	13.44	14.40	13.35	13.89	41.73L
2026-05-20	13.40	13.60	13.26	13.31	9.08L
2026-05-19	13.69	13.76	13.35	13.47	9.62L
2026-05-18	13.39	13.80	13.14	13.49	16.16L
2026-05-15	13.55	13.80	13.30	13.35	15.13L

About

Anlon Healthcare Limited (AHCL) is an Indian pharmaceutical company specializing in the manufacturing of high-purity advanced pharmaceutical intermediates, which serve as essential raw materials for the drug manufacturing process. The company operates both domestically and internationally, focusing on providing critical components for the pharmaceutical industry. Established in 1998, Anlon Healthcare has built a strong reputation for quality and reliability in supplying intermediates to various sectors, including generic and specialty drugs.